Endometrial cancer trials in China

In China 86 Also abroad 404

86 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment
Where
Beijing
Age
18 years to 40 years
People
81
Run by
Peking University People's Hospital
See details and how to joinNCT07318727
Phase 2Taking people
A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)
Where
Jinan
Age
18 years and over
People
30
Run by
GlaxoSmithKline
See details and how to joinNCT07108270
Phase 1/2Taking people
Study of GV20-0251 in Participants With Solid Tumor Malignancies
Where
Beijing, Shanghai
Age
18 years and over
People
350
Run by
GV20 Therapeutics
See details and how to joinNCT07070518
Phase 1Taking people
A Study of GV20-0251 in Advanced or Refractory Solid Tumors
Where
Chengdu
Age
18 years and over
People
10
Run by
West China Hospital
See details and how to joinNCT07106827
Phase 1/2Taking people
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies
Where
Shanghai
Age
18 years to 75 years
People
38
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT05803018
Phase 2Not yet taking people in China
Fruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial Cancer
Where
Guangzhou
Age
18 years to 75 years
People
128
Run by
Sun Yat-sen University
See details and how to joinNCT07170982
No phaseTaking people
Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment
Where
Beijing
Age
18 years and over
People
240
Run by
Peking University People's Hospital
See details and how to joinNCT06169449
No phaseTaking people
A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB
Where
Guangzhou, Shenzhen
Age
18 years and over
People
200
Run by
Sun Yat-sen University
See details and how to joinNCT06781151
No phaseTaking people
A Cohort Study of Uterine Malignancies
Where
Hangzhou
Age
20 years to 75 years
People
6,200
Run by
Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT05635123
Phase 2Not yet taking people in China
Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy
Where
Beijing
Age
18 years to 45 years
People
140
Run by
Peking University People's Hospital
See details and how to joinNCT06942377
No phaseTaking people
Cohort Study of Intrauterine Diseases
Where
Wuhan
Age
18 years to 80 years
People
2,000
Run by
Wenwen Wang
See details and how to joinNCT07048327
No phaseNot yet taking people in China
Patient Journey in Advanced Gynecologic Cancers
Where
Chongqing, Guangzhou, Hefei, Wuhan
Age
18 years and over
People
780
Run by
Tongji Hospital
See details and how to joinNCT07015593
No phaseTaking people
Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer
Where
Beijing
Age
17 years to 45 years
People
244
Run by
Peking University People's Hospital
See details and how to joinNCT05647109
Phase 2Taking people
Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Where
Beijing
Age
17 years to 45 years
People
38
Run by
Peking University People's Hospital
See details and how to joinNCT06102863
No phaseNot yet taking people in China
Application-Assisted Weight Management in Endometrial Cancer Fertility Preservation
Where
Beijing
Age
18 years to 60 years
People
106
Run by
Peking University People's Hospital
See details and how to joinNCT06901778
No phaseTaking people
PROfiling Based Endometrial Cancer Adjuvant Therapy
Where
Beijing, Changsha, Guangzhou, Hangzhou, Jinan, Ningbo, Shanghai, Wuhan
Age
18 years to 75 years
People
590
Run by
Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT05179447
Phase 1/2Taking people
A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor
Where
Baoding, Hangzhou, Harbin, Jinan, Kunming, Lianyungang, Linyi, Luoyang, Shanghai, Shenyang, Taiyuan, Weifang, Xi’an, Zhengzhou
Age
18 years to 75 years
People
282
Run by
Huabo Biopharm Co., Ltd.
See details and how to joinNCT06758557
Phase 2Not yet taking people in China
Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial
Where
Beijing, China
Age
18 years and over
People
140
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06771154
Phase 3Taking people
Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer
Where
Beijing, Changsha, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Jinan, Kunming, Nanning, Shanghai, Taiyuan, Tianjin, Wenzhou, Xi'an, Zhengzhou
Age
18 years to 75 years
People
412
Run by
Hutchmed
See details and how to joinNCT06584032
Phase 2Not yet taking people in China
QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer
Where
Beijing
Age
18 years to 75 years
People
26
Run by
xiang yang
See details and how to joinNCT06751277
Phase 1Not yet taking people in China
A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway
Where
Beijing, Beijjing
Age
18 years and over
People
112
Run by
Danatlas Pharmaceuticals Co., Ltd
See details and how to joinNCT06614751
Phase 2Taking people
HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer
Where
Beijing, Changchun, Changsha, Chongqing, Dalian, Fuzhou, Guangzhou, Haikou, Hanzhou, Harbin, Hefei, Jinan, Kunming, Nanjing, Nanning, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Wuhan, Xi’an, Xinjiang, Zhengzhou
Age
18 years and over
People
460
Run by
Hansoh BioMedical R&D Company
See details and how to joinNCT06014190
Phase 2Not yet taking people in China
Oral Topotecan With Toripalimab for Patients With Endometrial Cancer
Where
Shanghai
Age
18 years and over
People
30
Run by
Fudan University
See details and how to joinNCT06548763
Phase 3Not yet taking people in China
Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer
Where
Beijing, Binzhou, Changchun, Changsha, Chongqing, Fuzhou, Guangzhou, Guigang, Guilin, Haikou, Hangzhou, Harbin, Hefei, Hohhot, Huizhou, Jiangmen, Jinan, Jining, Kunming, Lanzhou, Linyi, Liuzhou, Luoyang, Meizhou, Nanning, Nanyang, Ningbo, Shanghai, Shaoyang, Shenyang, Taiyuan, Tangshan, Tianjin, Ürümqi, Weifang, Wuhan, Xi'an, Xi’an, Xining, Yantai, Yinchuan, Zaozhuang, Zhengzhou
Age
18 years and over
People
420
Run by
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT06475599
Phase 1Taking people
CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors
Where
Guangzhou
Age
18 years to 75 years
People
200
Run by
Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05410717